Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

PCOS showdown: which drug tames hormones better?

NCT ID NCT07459595

Disease control Sponsor: Fatima Tariq Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two drugs—metformin and myo-inositol—for managing polycystic ovary syndrome (PCOS) in 60 women. Over 3 months, researchers will check if either drug helps restore regular menstrual cycles and improve hormone balance. The goal is to see which option works better for common PCOS symptoms like irregular periods and excess hair growth.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Metformin and myo-inositol
What this could lead to
If one works better, it could offer a simpler, more effective option for managing PCOS symptoms like irregular periods and hormone levels.
What could go wrong
This is a very early, small phase 1 trial with only 60 participants, so results may not apply broadly. Both drugs have known side effects like stomach upset.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Married or unmarried * Diagnosed with PCOS (females presenting with compliant of irregular cycle for \>3 months, with hirsutism, acne, presence of polycystic ovaries detected on ultrasound ). Exclusion Criteria: * Females already taken or taking PCOS treatment (on medical record) * Females already enrolled in another trial program * Females already taking trial drugs * Females with chronic diabetes (BSR\>200 mg/dl), hypertension (BP≥140/90mmHg) * Females with PCOS along with gestational sac (on ultrasound) * Females allergic to any content of trial drugs (on history)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Polycystic ovarian syndrome (PCOS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Polycystic ovarian syndrome (PCOS)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CMH Gujranwala

    Guiranwala, Punjab Province, 52230, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.